Clinical Trials Browser

Observational × Stomach Neoplasms × Observation × Clear all

Stomach Neoplasms, Helicobacter Infections

NCT07400354 2026-02-10

The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota

Recruiting

300 enrolled

Gastrointestinal

Stomach Neoplasms

NCT05179824 2025-05-06

Tempus Priority Study: A Pan-tumor Observational Study

Active not recruiting

1,000 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcomaThoracic

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT05924789 2025-02-12

GASPAR

Completed

120 enrolled

Gastrointestinal

Pancreatic Neoplasms, Stomach Neoplasms

NCT06706466 2024-11-26

Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.

Completed

410 enrolled

Gastrointestinal

Stomach Neoplasms

NCT06493448 2024-07-10

Prospective Observational Cohort Study

Not yet recruiting

1,326 enrolled

Gastrointestinal

Stomach Neoplasms

NCT06335576 2024-03-28

Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application

Not yet recruiting

89 enrolled

Gastrointestinal

Stomach Neoplasms

NCT04439812 2020-06-19

Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer

Completed

267 enrolled

Gastrointestinal

Margins of Excision, Recurrence, Stomach Neoplasms

NCT03314649 2019-05-08

Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric Cancer

Completed

200 enrolled

Gastrointestinal

Stomach Neoplasms

NCT00767234 2016-07-11

Permission to Collect Blood Over Time for Research

Terminated

104 enrolled

GastrointestinalSarcoma

Anus Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Gastrointestinal Stromal Tumors

Clinical Trials

An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori

The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota

Tempus Priority Study: A Pan-tumor Observational Study

GASPAR

Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.

Prospective Observational Cohort Study

Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application

Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer

Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric Cancer

Permission to Collect Blood Over Time for Research